Abstract
Answer E. Semaglutide
Medications identified as risk factors include octreotide, glucagon-like peptide-1 analogues, hormone replacement therapy (HRT) and ceftriaxone.
InnovAiT article: Gallbladder disease. DOI: 10.1177/17557380241292803.
You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026
Filter Results
Select search scope: search across all journals or within the current journal
Search this journal
Enter search terms…
/